Healthcare provider profile · identity verified

David Covert, PA-C

Physician Assistant · MONTOURSVILLE, PA · NPI 1295286508

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	515	150
Levothyroxine Sodium	Levothyroxine Sodium	362	94
Lisinopril	Lisinopril	342	91
Omeprazole	Omeprazole	304	87
Amlodipine Besylate	Amlodipine Besylate	238	70
Gabapentin	Gabapentin	222	59
Simvastatin	Simvastatin	175	48
Furosemide	Furosemide	150	48
Ozempic	Semaglutide	149	34
Metoprolol Succinate	Metoprolol Succinate	139	40
Sertraline Hcl	Sertraline Hcl	139	38
Metformin Hcl Er	Metformin Hcl	138	41
Albuterol Sulfate Hfa	Albuterol Sulfate	127	48
Losartan Potassium	Losartan Potassium	123	35
Eliquis	Apixaban	121	33
Tamsulosin Hcl	Tamsulosin Hcl	121	34
Jardiance	Empagliflozin	111	30
Metformin Hcl	Metformin Hcl	107	32
Oxycodone Hcl	Oxycodone Hcl	106	27
Tramadol Hcl	Tramadol Hcl	101	38
Montelukast Sodium	Montelukast Sodium	98	28
Rosuvastatin Calcium	Rosuvastatin Calcium	97	36
Trazodone Hcl	Trazodone Hcl	93	25
Metoprolol Tartrate	Metoprolol Tartrate	91	32
Tizanidine Hcl	Tizanidine Hcl	90	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	87	24
Fluticasone Propionate	Fluticasone Propionate	86	32
Atenolol	Atenolol	78	22
Prednisone	Prednisone	78	59
Duloxetine Hcl	Duloxetine Hcl	71	20
Baclofen	Baclofen	68	18
Citalopram Hbr	Citalopram Hydrobromide	68	16
Lorazepam	Lorazepam	68	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	66	18
Pantoprazole Sodium	Pantoprazole Sodium	64	15
Trulicity	Dulaglutide	64	13
Ezetimibe	Ezetimibe	63	13
Glipizide	Glipizide	62	20
Fluoxetine Hcl	Fluoxetine Hcl	58	16
Hydrochlorothiazide	Hydrochlorothiazide	57	19
Potassium Chloride	Potassium Chloride	55	18
Venlafaxine Hcl Er	Venlafaxine Hcl	55	12
Carvedilol	Carvedilol	54	14
Pravastatin Sodium	Pravastatin Sodium	52	15
Clopidogrel	Clopidogrel Bisulfate	51	15
Buspirone Hcl	Buspirone Hcl	50	15
Meloxicam	Meloxicam	48	21
Diclofenac Sodium	Diclofenac Sodium	47	16
Ropinirole Hcl	Ropinirole Hcl	47	11
Famotidine	Famotidine	45	21
Finasteride	Finasteride	39	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	39	25
Donepezil Hcl	Donepezil Hcl	37	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	36	21
Pregabalin	Pregabalin	35	16
Doxycycline Hyclate	Doxycycline Hyclate	34	31
Alendronate Sodium	Alendronate Sodium	33	suppressed
Alprazolam	Alprazolam	33	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	31
Hydroxyzine Hcl	Hydroxyzine Hcl	33	11
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	30	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	11
Clonazepam	Clonazepam	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	15
Quetiapine Fumarate	Quetiapine Fumarate	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	11
Mounjaro	Tirzepatide	28	suppressed
Naproxen	Naproxen	28	suppressed
Nystatin	Nystatin	28	13
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Benazepril Hcl	Benazepril Hcl	27	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	suppressed
Allopurinol	Allopurinol	25	suppressed
Azithromycin	Azithromycin	25	17
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Methylprednisolone	Methylprednisolone	25	24
Warfarin Sodium	Warfarin Sodium	25	suppressed
Celecoxib	Celecoxib	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Ventolin Hfa	Albuterol Sulfate	24	suppressed
Ondansetron Odt	Ondansetron	23	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Repaglinide	Repaglinide	22	suppressed
Topiramate	Topiramate	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	16
Acetaminophen-Codeine	Acetaminophen With Codeine	21	suppressed
Fenofibrate	Fenofibrate,micronized	21	suppressed
Torsemide	Torsemide	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Rizatriptan	Rizatriptan Benzoate	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Varenicline Tartrate	Varenicline Tartrate	17	suppressed
Amoxicillin	Amoxicillin	16	12
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Carbamazepine	Carbamazepine	14	suppressed
Fluconazole	Fluconazole	14	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Testosterone	Testosterone	14	suppressed
Cephalexin	Cephalexin	13	12
Latanoprost	Latanoprost	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Risperidone	Risperidone	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Colchicine	Colchicine	12	suppressed
Mesalamine Dr	Mesalamine	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error